About The Doctor

Dr. Pasi A. Janne

Medical Oncologist , Associate Professor of Medicine, Medical Oncologist

Dr. Pasi A. Janne, M.D., Ph.D., works as the director for the Translational Research Laboratory. He's a practicing oncologist and researcher, and his main interest in clinical research is studying epidermal growth factor reception mutations for non-small cell lung cancer. He looks at the impact this has on targeted therapeutic treatment.

Get In Touch

Dr. Jänne’s Education

Dr. Pasi Jänne earned his M.D. and his Ph.D. from the University of Pennsylvania. He completed his internal medicine residency at the Brigham and Women’s Hospital and his oncology fellowship at Brigham’s Dana-Farber Cancer Institute.

Dr. Jänne currently practices as a medical oncologist at the Dana-Farber Cancer Institute, where he serves as Director for the Thoracic Oncology, Applied Cancer Science, and EGFR Mutant Lung Cancers programs. His special areas of interest include lung cancer and cancer drug resistance.

Message of Hope

Dr. Pasi Jänne tests molecular targets to develop novel treatments for asbestos-related cancers.


Dr. Jänne works with a team of collaborators from 12 different countries. He is one of the co-discoverers of EGFR mutations in non-small cell lung cancer. Dr. Jänne focuses on understanding the mechanisms of drug-resistant lung cancer.

Innovative Approaches

Along with his team of colleagues, Dr. Jänne tests molecular targets to develop novel treatments for asbestos-related cancers. He works to develop innovative treatment approaches, such as immunotherapy, photodynamic therapy, and intracavitary heat chemotherapy.

When facing a diagnosis of an asbestos-related cancer like lung cancer, it is crucial to find the right treatment right away. Contact Dr. Pasi Jänne today.

Article Sources